VITAMINS, COMMON INFORMATION

New Drug Approvals

A vitamin (US /ˈvaɪtəmɪn/ or UK /ˈvɪtəmɪn/) is an organic compound required by an organism as a vital nutrient in limited amounts. An organic chemical compound (or related set of compounds) is called a vitamin when it cannot be synthesized in sufficient quantities by an organism, and must be obtained from the diet. Thus, the term is conditional both on the circumstances and on the particular organism. For example, ascorbic acid (vitamin C) is a vitamin for humans, but not for most other animals, and biotin (vitamin H) and vitamin D are required in the human diet only in certain circumstances.

 

 

 

 

Thiamin What it does: helps convert…

View original post 1,230 more words

 

HOME REMEDIES FOR CHOLESTEROL

New Drug Approvals

Home Remedies for Cholesterol: Onions contain high levels of quercetin, an important flavonoid that reduces cholesterol. high concentrations of the compound quercetin hinderS the oxidation process of LDL, or “bad,” cholesterol, which help prevent the negative effects of this type of cholesterol.

===> http://www.askveda.in/ – Ayurveda health-tips, home remedies & expert advice

View original post

 

NATURE’S VIAGRA-Health benefits of pomegranate by – By Dr. Janardhana V Hebbar, Ayurveda Expert

New Drug Approvals

Countless studies have shown the seemingly countless benefits of fruits for a person’s health.

The U.S. Government recommends that people get some servings of fruits every day. Of all the fruits ready in the shop today,

one fruit is at its height of popularity because of its legendary Greek mythology connection and its exoticism-the pomegranate fruit.

READ COMPLETE ARTICLE AT

http://www.askveda.in/blog/health-benefits-of-pomegranate/

 

 

View original post

 

GLENMARK-A new way for a new world

New Drug Approvals

http://www.glenmarkpharma.com/GLN_NWS/homepage.aspx?res=P_GLN

http://www.glenmark-generics.com/

Type	Public
Traded as	BSE: 532296NSE: GLENMARK)
Industry	Pharmaceuticals, Drugs &Healthcare
Founded	1977
Founder(s)	Gracias Saldanha
Headquarters	Mumbai, Maharashtra[1], India
Key people	Glenn Saldanha, MD & CEO [2]
Products	Medicines and Vaccines
Revenue	1031.10 crore(US$160 million) (2009–2010)[3]
Employees	7,000 [4]
Subsidiaries	Glenmark Generics Ltd[5]
Website	www.glenmarkpharma.com

Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. ^[6] It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as Dermatology, Internal Medicine, Paediatrics, Gynaecology, ENT andDiabetes.

It has four manufacturing facilities for formulations and additional three facilities for APIs. These manufacturing facilities are located in the states of Maharashtra, Goa, Himachal Pradesh and Gujarat in India.

It…

View original post 1,595 more words

 

Bupropion review

New Drug Approvals

Bupropion

Bupropion (/bjuːˈproʊpi.ɒn/ bew-proh-pee-on;^[2] ) is a drug that is primarily used as an atypical antidepressant and smoking cessation aid. Marketed as Wellbutrin, Budeprion, Prexaton, Elontril, Aplenzin, or other trade names, it is one of the most frequently prescribed antidepressants in the United States. Marketed in lower-dose formulations as Zyban, Voxra, or other names, it is also widely used to reduce nicotine cravings by people who are trying to quit smoking. It is taken in the form of pills, and in the United States is available only by prescription.

Bupropion lowers seizure threshold, and its potential to cause seizures has been widely publicized. Bupropion is an effective antidepressant on its own, but it is also popular as an add-on medication in cases of incomplete…

View original post 2,551 more words

 

ATORVASTATIN SYNTHESIS

New Drug Approvals

atorvastatin

Atorvastatin (INN) /əˌtɔrvəˈstætən/, marketed by Pfizer as a calcium salt under the trade name Lipitor,^[1] is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammatory and other mechanisms. Like all statins, atorvastatin works by inhibitingHMG-CoA reductase, an enzyme found in liver tissue that plays a key role in production of cholesterol in the body.

Atorvastatin was first synthesized in 1985 by Bruce Roth of Parke-Davis Warner-Lambert Company (since acquired by Pfizer). The best selling drug in pharmaceutical history, sales of Lipitor since it was approved in 1996 exceed US$125 billion, and the drug has topped the list of best-selling branded pharmaceuticals in the world for nearly a decade.^[2] When Pfizer’s patent on…

View original post 939 more words

 

Small molecule, API biz to be growth drivers for company: Kiran Mazumdar Shaw, Biocon

New Drug Approvals

“We have focused on creating key growth drivers and have structured the company along those growth drivers,” says Kiran Mazumdar Shaw. (BCCL)…………. owner BIOCON

MY, DR AMC  COMMENTS- BIOCON GREAT PERFORMANCE, U ARE EVERYWHERE

 

Kiran Mazumdar Shaw: We have focused on creating key growth drivers and have structured the company along those growth drivers. These growth drivers are beginning to deliver very strongly for us.

The first is our small molecule business vertical, which is about our historic statins and immunosuppressant’s API business. This particular vertical going forward is envisioned to go up the value chain along an ANDA path and we believe that will improve the quality of earnings in this particular vertical, which for a long time was under pressure because of commoditisation of statins.http://economictimes.indiatimes.com/opinion/interviews/small-molecule-api-biz-to-be-growth-drivers-for-company-kiran-mazumdar-shaw-biocon/articleshow/21975113.cms

View original post

 

Alnylam Hemophilia Drug Garners Orphan Drug Status

New Drug Approvals

CAMBRIDGE, Mass., Aug 14, 2013 (AP) — The Food and Drug Administration has granted an “orphan drug designation” to a potential hemophilia treatment from Alnylam Pharmaceuticals Inc.

Orphan drug status is awarded to drugs that could treat diseases that affect fewer than 200,000 people in the United States. It comes with some added marketing exclusivity.

The Cambridge, Mass., company said Wednesday that the agency gave the designation to a drug labeled ALN-AT3 for the treatment of hemophilia B. Alnylam has tested the drug in mice and plans to start studies involving humans early next year.

for the treatment of hemophilia B. Alnylam has tested the drug in mice and plans to start studies involving humans early next year.

http://www.pharmalive.com/alnylam-hemophilia-drug-garners-orphan-drug-status

 

View original post

 

Propecia Could Save 70,000 Men From Prostate Cancer

New Drug Approvals

finasteride

The baldness drug propecia could help reduce the risk of prostate cancer with less side-effects than previously thought, according to a new study.

By Amir Khan, Everyday Health Staff Writer

Warding off prostate cancer may be as easy as growing your hair, according to new data published in the New England Journal of Medicine by researchers from the University of Texas Health Science Center at San Antonio. The researchers followed up on patients from one of their previous studies, and found that the baldness drug finasteride, also known as Propecia, reduced the risk of prostate cancer by more than a third, and resulted in less-severe side effects than previously thought.

“If you look at the number of prostate cancers that are diagnosed annually and multiply that by 30 percent, that’s the number of cancers we might be able to prevent each year,” Ian Thompson Jr., MD, study author and director…

View original post 188 more words

 

Need For A Smarter Regulatory System To Ensure Access To Affordable Biologics: The Biosimilars

New Drug Approvals

by

Kiran Mazumdar Shaw, MD, BIOCON

The global pharmaceutical industry is going through a paradigm change as biologics such as monoclonal antibodies and recombinant proteins find greater acceptance for treating a wide range of chronic diseases.

Today biologics make for up half of the top 10 best-selling drugs worldwide.

http://kiranmazumdarshaw.blogspot.in/2013/08/need-for-smarter-regulatory-system-to_13.html

View original post